SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Street Walker who wrote (1376)11/4/1999 7:53:00 AM
From: Dan P  Read Replies (1) of 5582
 
SW:

According to your numbers, Gumm could net $17 million or
more based on $1.75 per bottle profit. At around 7.5
million shares, net earnings of approximately $2.50.

Those are some staggering potential earnings, if they
come through. Obviously, success will depend on the
results from the additional studies. International
distribution will smooth out the curve over the 12 month
period, since of course colds are mostly a winter phenomenon
in the US.

Cheers

Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News